XKRX:278650 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
3900.00
(+0.91%)
Apr 24
Business Description
HLB BioStep Co Ltd
ISIN : KR7278650007
Share Class Description:
XKRX:278650: Ordinary SharesCompare
Compare
Traded in other countries / regions
278650.Korea IPO Date
2019-11-27Description
HLB BioStep Co Ltd provides non-clinical services necessary for leading domestic and foreign pharmaceutical companies and bio ventures in the process of developing drugs and health functional foods.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.16 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.6 | |||||
| Debt-to-EBITDA | 8.34 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.63 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.8 | |||||
| 3-Year EBITDA Growth Rate | -19.5 | |||||
| 3-Year FCF Growth Rate | -47.6 | |||||
| 3-Year Book Growth Rate | 17 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.26 | |||||
| 9-Day RSI | 50.6 | |||||
| 14-Day RSI | 50.67 | |||||
| 6-1 Month Momentum % | 51.92 | |||||
| 12-1 Month Momentum % | -7.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.23 | |||||
| Quick Ratio | 1.2 | |||||
| Cash Ratio | 1.09 | |||||
| Days Inventory | 34.61 | |||||
| Days Sales Outstanding | 38.55 | |||||
| Days Payable | 36.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.7 | |||||
| Shareholder Yield % | 8.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.13 | |||||
| Operating Margin % | -2.25 | |||||
| Net Margin % | -0.31 | |||||
| FCF Margin % | 2.25 | |||||
| ROE % | -0.18 | |||||
| ROA % | -0.1 | |||||
| ROIC % | 0.17 | |||||
| ROC (Joel Greenblatt) % | 9.05 | |||||
| ROCE % | 2.97 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 3365.13 | |||||
| PS Ratio | 5.94 | |||||
| PB Ratio | 3.09 | |||||
| Price-to-Tangible-Book | 3.14 | |||||
| Price-to-Free-Cash-Flow | 194.95 | |||||
| Price-to-Operating-Cash-Flow | 56.39 | |||||
| EV-to-EBIT | 84.41 | |||||
| EV-to-EBITDA | 44.07 | |||||
| EV-to-Revenue | 6.08 | |||||
| EV-to-FCF | 268.78 | |||||
| Price-to-Net-Current-Asset-Value | 33.72 | |||||
| Price-to-Net-Cash | 1238.1 | |||||
| Earnings Yield (Greenblatt) % | 1.18 | |||||
| FCF Yield % | 0.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HLB BioStep Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 52,814.063 | ||
| EPS (TTM) (â‚©) | -2 | ||
| Beta | 0.97 | ||
| Volatility % | 50.9 | ||
| 14-Day RSI | 50.67 | ||
| 14-Day ATR (â‚©) | 234.931189 | ||
| 20-Day SMA (â‚©) | 3961.25 | ||
| 12-1 Month Momentum % | -7.03 | ||
| 52-Week Range (â‚©) | 2430 - 4910 | ||
| Shares Outstanding (Mil) | 84.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HLB BioStep Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HLB BioStep Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
HLB BioStep Co Ltd Frequently Asked Questions
What is HLB BioStep Co Ltd(XKRX:278650)'s stock price today?
The current price of XKRX:278650 is â‚©3900.00. The 52 week high of XKRX:278650 is â‚©4910.00 and 52 week low is â‚©2430.00.
When is next earnings date of HLB BioStep Co Ltd(XKRX:278650)?
The next earnings date of HLB BioStep Co Ltd(XKRX:278650) is .
Does HLB BioStep Co Ltd(XKRX:278650) pay dividends? If so, how much?
HLB BioStep Co Ltd(XKRX:278650) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers